Affective disorder in the neurological patient

La dépression dans les populations médicales

La prévalence élevée des états dépressifs dans la clientèle du généraliste (environ 10% des consultants) et chez les patients de médecine interne (15 à 25% des hospitalisés) est maintenant bien établie. Ce fait a été longtemps négligé par les praticiens et les psychiatres; même actuellement son importance reste sous-estimée.

La proportion d’états dépressifs non-identifiés par les praticiens varie de 1/3 à 2/3 selon les études. Les dépressions méconnues sont source de surconsommation médicale (consultations répétées, examens paracliniques, hospitalisations pour bilans) et ont une évolution moins favorable, plus chronique, que les dépressions identifiées et correctement traitées. Des cas sévères de dépression échappent souvent au dépistage, ce qui n’est pas sans conséquences graves: on sait en effet que la majorité des gens qui se suicident ont consulté un médecin dans le mois qui a précédé leur décès.

Parmi les facteurs qui rendent compte de la méconnaissance des états dépressifs par les médecins non-spécialistes, les uns tiennent aux patients qui, dans leur dialogue avec le généraliste, utilisent davantage le langage de la somatisation qu’ils ne verbalisent explicitement un vécu dépressif. D’autres tiennent aux praticiens, à leur intérêt prévalent et parlois exclusif pour les problèmes somatiques, à leur souci légitime de ne pas passer à côté du diagnostic d’une affection médicale, à l’idée qu’ils se font de la dépression et des déprimés, à leur propension à considérer toutes les manifestations dysphoriques comme conséquences légitimes de la maladie physique. Il faut aussi compter avec les conditions d’exercice du généraliste, le temps très court de sa consultation où il n’est pas facile de différencier une réelle pathologie dépressive, généralement liée à des troubles anxieux et moins nette que dans les consultations Psychiatriques, de troubles émotionnels mineurs, situationnels et transitoires.

Les instruments habituellement utilisés pour le dépistage et le diagnostic de la dépression (échelles d’autoévaluation, critères de diagnostic type RDC ou critères du DSM III) n’ont pas été validés pour les populations de patients somatiques. Récemment deux nouveaux instruments viennent d’être mis au point pour la détection de la symptomatologie dépressive chez les patients somatiques: I'échelle HAD (Hospital Anxiety and Depression Scale) de Zigmond et Snaith (1983) et le Questionnaire Abrégé d’Auto-Évaluation de la Symptomatologie Dépressive (QD2A) de Pichot et al. (1984). Ces échelles, de passation rapide et bien acceptées par les patients, peuvent servir d’aide au diagnostic pour le praticien dans la perspective d’un meilleur dépistage de la dépression et d’une prise en charge plus efficace des déprimés.

The role of psychiatry in genetic prediction programmes for Huntington's disease

Psychiatrists are becoming increasingly involved in the assessment of candidates for genetic testing for Huntington's disease (HD) in which their role ranges from diagnosing conventional psychiatric disorder to identifying ‘new odd behaviours'. They are also expected to predict dysfunctional response to test results (e.g. self-harm). This paper describes the psychiatric component of the Cambridge HD Clinic and its assessment protocols. Practical concepts, useful to the understanding of the clinical problems that may be encountered, are also discussed.

Alternative cognitive therapy for emotional instability (pathologic laughing and crying)

Emotional instability (EI) is involuntary laughing and crying associated with brain damage seen in a variety of disorders. This article discusses occurrence, impact, and diagnosis, and neuroanatomic substrates underlying proposed mechanisms producing EI are outlined and related to traditional drug treatment. An expanded neuroanatomic model is suggested emphasizing the prefrontal cortex as the center integrating information from a complex emotion and sensory loop with motor information destined for the faciorespiratory nuclei in the brainstem. Disturbance at any level in the loop is proposed to produce EI by degrading information to or from the prefrontal cortex, disrupting its inhibitory control of the nuclei. An alternative cognitive therapy for EI was developed to compensate for deficits resulting from structural lesions by strengthening undamaged pathways, which is achieved by superimposing volitional movement on muscles affected during an EI episode. Treatment of 17 patients showed significant reductions in EI severity and occurrence, and in contrast to drug treatments,the effect was sustained at 3- to 6-month follow-up.

Depressive symptom patterns and their consequences for diagnosis of affective disorders in cancer patients

GOALS OF WORK

In order to obtain references for adequate diagnostic procedures of depressive syndromes in cancer patients, the present study analyzes first the prevalence of somatic, emotional, and cognitive symptoms of depression. In a second part, the ability of diagnostic procedures to discriminate between patients with and without comorbid affective disorder is investigated.

PATIENTS AND METHODS

From a cross-sectional survey investigating comorbid mental disorders in cancer patients with standardized clinical assessment, a subsample of 71 patients with current affective disorders and depressive symptoms according to the Diagnostic and Statistic Manual of Mental Disorders, 4th edition (DSM-IV) were analyzed. In addition to patients' symptom patterns, a discriminant analysis including all depressive symptoms was conducted.

MAIN RESULTS

Cognitive symptoms are less prevalent in cancer patients than somatic and emotional symptoms. Loss of interest discriminated best between patients with and without diagnosis of comorbid affective disorder. Additionally, decreased energy and fatigue proved to have discriminatory value.

CONCLUSIONS

Cognitive symptoms should receive special attention in diagnostic procedures for affective disorders in cancer patients. In spite of possible symptom overlap with the cancer disease and its treatment, fatigue proves to be a useful criteria for diagnosis of depression.

Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects

OBJECTIVE

Psychiatric profiles of two at-risk groups [Huntington's disease (HD) gene carriers and non-carriers] were compared by means of a computerized battery and a structured interview.

METHOD

To avoid confounding, only subjects who were free from neurological and cognitive deficits (neurologically asymptomatic) were included in the study. To avoid evaluation biases, all subjects were seen before the genetic testing was undertaken.

RESULTS

Gene carriers had significantly worse recognition memory and scored higher in measures of irritability than controls. The groups also differed in terms of the factor structure of their psychiatric symptoms. None of the subjects qualified for a psychiatric diagnosis at the time of assessment.

CONCLUSION

The groups differed with respect to their profile of psychiatric symptoms. It is hypothesized that these differences are the expression of different mechanisms, i.e. that cognitive deficits relate more to genetic factors and neurotic complaints more to being brought up in a disturbed family background. Issues concerning instrument sensitivity, selection bias and the advantage of seriatim assessments are discussed.

Bibliotherapy for psychosocial distress in lung transplant patients and their families

Thirty-six lung transplant candidates (n = 16), recipients (n = 11), and support people (n = 9) were examined for psychological distress, coping style, and orientation to independent learning before and after receiving a self-help book in a program designed to alleviate psychosocial distress and bolster adaptive coping. The subjects rated the book as highly acceptable, and none reported increased psychological distress. A further six subjects completed initial psychological measures but elected not to us the book. These subjects were compared with study completers and found to have significantly higher disengagement scores on the Coping Strategies Inventory. Although uncontrolled, significant changes were observed in coping strategies used by the completer group. The relevance of these findings to the use of bibliotherapy in medically ill populations is discussed.

Autonomic failure, depression and anxiety in Parkinson's disease

BACKGROUND

The study tested the hypothesis that subjects with Parkinson's disease (PD) have more autonomic complaints and more attenuation of autonomic reflexes than controls, and that both clusters of variables are related to the presence of anxiety and depression.

METHOD

Thirty-two subjects and 32 healthy controls matched by age and sex were prospectively compared on psychiatric, cognitive and autonomic tests.

RESULTS

'Autonomic' symptoms: were more frequent in PD patients than in healthy controls; were not related to age or changes in autonomic reflexes; were significantly associated with depression and anxiety (medication was not relevant to the association); and did not correlate with motor symptoms.

CONCLUSIONS

The diagnosis of anxiety and depression in some PD subjects is likely to be a behavioural phenocopy caused by autonomic failure. This explains why antidepressant medication is often unhelpful in PD subjects diagnosed as depressed.

The delayed neurobehavioural sequelae of traumatic brain injury

This is a comprehensive review of the late-occurring effects of traumatic brain injury (TBI). It appears that TBI increases the risk over basal rates for the general population, to this degree: for depression, by a factor of five or 10; for seizures, by two to five; for psychotic disorders, by the same factor; and for dementia, by four or five. Severe TBI, or injuries with special characteristics, may increase the risk of delayed sequelae even further. One is not able, at this point, to estimate the relative occurrence of a newly described entity--delayed amnesia. An initial TBI increases the risk for subsequent TBI, by a factor of two. A second TBI increases the risk of yet another TBI eightfold.

Depressive illness in multiple sclerosis. Clinical and theoretical aspects of the association

The present state of knowledge of the possible relationship between depressive illness and multiple sclerosis is described. Problems of the research methodology are identified and suggestions made for useful areas of inquiry.